Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de Feijter-Rupp, H. L.
Right arrow Articles by Trosko, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Feijter-Rupp, H. L.
Right arrow Articles by Trosko, J. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 747-754, Copyright © 1998 by Oxford University Press


ARTICLES

Restored gap junctional communication in non-tumorigenic HeLa-normal human fibroblast hybrids

HL de Feijter-Rupp, T Hayashi, GH Kalimi, P Edwards, JL Redpath, CC Chang, EJ Stanbridge and JE Trosko
Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing 48824, USA.

Gap junctional intercellular communication (GJIC) has been implicated in homeostasis, development, differentiation, wound healing or regeneration and adaptive responses of differentiated cells. The dysfunction of homologous or heterologous GJIC has been associated with the tumorigenic phenotype. Restoration of growth control and the suppression of the tumorigenic phenotype have been previously associated with the up-regulation of GJIC by various anti-tumorigenic chemicals or transfection of connexin genes into tumor cells. To test the hypothesis that 'tumor suppressor' genes may be associated with the up-regulation of GJIC, we tested clones of tumorigenic HeLa, several non-tumorigenic HeLa-normal human fibroblast somatic cell hybrids and a tumorigenic segregant of one of the non-tumorigenic hybrids for GJIC. The parental HeLa cells (D98 AH.2) had no detectable GJIC but expressed detectable connexin 43 transcripts, while the non-tumorigenic HeLa- human fibroblast hybrids, which contained the chromosome 11 from the normal human fibroblast (CGL-1, CGL-2, ESH15 and EHS15c1), expressed ample connexin 43 transcripts and showed proficient GJIC. The tumorigenic segregant (CGL-3) from the non-tumorigenic HeLa-human fibroblast hybrid showed no GJIC or connexin 43. These results show that the presence of GJIC is closely linked to the suppression of the tumorigenic phenotype in the HeLa-human fibroblast hybrid and further suggest that GJIC may be associated with the mechanisms of tumor suppression. The mechanism by which the tumor suppressor gene(s) on the normal chromosome in the HeLa-human fibroblasts induces the up- regulation of connexin 43 is not yet explained.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
J. Witteveldt, M. J. Evans, J. Bitzegeio, G. Koutsoudakis, A. M. Owsianka, A. G. N. Angus, Z.-Y. Keck, S. K. H. Foung, T. Pietschmann, C. M. Rice, et al.
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
J. Gen. Virol., January 1, 2009; 90(1): 48 - 58.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Nakamura, C.-C. Chang, T. Mori, K. Sato, K. Ohtsuki, B. L. Upham, and J. E. Trosko
Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells
Carcinogenesis, March 1, 2005; 26(3): 665 - 671.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.